133 related articles for article (PubMed ID: 10822297)
1. Prokaryotic gene therapy to combat multidrug resistant bacterial infection.
Norris JS; Westwater C; Schofield D
Gene Ther; 2000 May; 7(9):723-5. PubMed ID: 10822297
[No Abstract] [Full Text] [Related]
2. [Use of bacteriophage therapy in surgical practice].
Lakhno VM; Bordunovskiĭ VN
Vestn Khir Im I I Grek; 2001; 160(1):122-5. PubMed ID: 11258316
[No Abstract] [Full Text] [Related]
3. Bacteriophage therapy for the treatment of infections.
Górski A; Miedzybrodzki R; Borysowski J; Weber-Dabrowska B; Lobocka M; Fortuna W; Letkiewicz S; Zimecki M; Filby G
Curr Opin Investig Drugs; 2009 Aug; 10(8):766-74. PubMed ID: 19649921
[TBL] [Abstract][Full Text] [Related]
4. Bacteriophage therapy of bacterial infections: an update of our institute's experience.
Weber-Dabrowska B; Mulczyk M; Górski A
Arch Immunol Ther Exp (Warsz); 2000; 48(6):547-51. PubMed ID: 11197610
[TBL] [Abstract][Full Text] [Related]
5. Technology, medicine & health, Part 9. Multi-drug resistance and other "wildcard" diseases.
Davidson SN
Healthc Forum J; 1996; 39(1):42-7. PubMed ID: 10154110
[No Abstract] [Full Text] [Related]
6. Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986.
Slopek S; Weber-Dabrowska B; Dabrowski M; Kucharewicz-Krukowska A
Arch Immunol Ther Exp (Warsz); 1987; 35(5):569-83. PubMed ID: 3455647
[TBL] [Abstract][Full Text] [Related]
7. Bacteriophage therapy in children: facts and prospects.
Fortuna W; Miedzybrodzki R; Weber-Dabrowska B; Górski A
Med Sci Monit; 2008 Aug; 14(8):RA126-32. PubMed ID: 18668009
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of multidrug resistant bacterial infections during resuscitation].
Soins; 1997 Nov; (620):24-5. PubMed ID: 9479202
[No Abstract] [Full Text] [Related]
9. [Isolation precautions. Multidrug resistant bacteria].
Fuchs D
Soins; 1997 Nov; (620):22-3. PubMed ID: 9479201
[No Abstract] [Full Text] [Related]
10. [Phagotherapy in terms of bacteriophage genetics: hopes, perspectives, safety, limitations].
Krylov VN
Genetika; 2001 Jul; 37(7):869-87. PubMed ID: 11558226
[TBL] [Abstract][Full Text] [Related]
11. [V.A.C.-therapy as a hygienic procedure tool: protection of the environment of wounds and patients with multiresistant bacteria in clinical and outpatient treatment].
Wetzel-Roth W
Zentralbl Chir; 2006 Apr; 131 Suppl 1():S180-1. PubMed ID: 16575677
[No Abstract] [Full Text] [Related]
12. [New perspectives of the phage therapy].
Eyer L; Pantůcek R; Růzicková V; Doskar J
Klin Mikrobiol Infekc Lek; 2007 Dec; 13(6):231-5. PubMed ID: 18320502
[TBL] [Abstract][Full Text] [Related]
13. Treatment of post-burns bacterial infections by bacteriophages, specifically ubiquitous Pseudomonas spp. notoriously resistant to antibiotics.
Ahmad SI
Med Hypotheses; 2002 Apr; 58(4):327-31. PubMed ID: 12027527
[TBL] [Abstract][Full Text] [Related]
14. Adenoviral delivery of A-FOS, an AP-1 dominant negative, selectively inhibits drug resistance in two human cancer cell lines.
Bonovich M; Olive M; Reed E; O'Connell B; Vinson C
Cancer Gene Ther; 2002 Jan; 9(1):62-70. PubMed ID: 11916245
[TBL] [Abstract][Full Text] [Related]
15. [New trends in therapeutic use of bacteriophages].
Vieu JF; Guillermet F; Minck R; Nicolle P
Bull Acad Natl Med; 1979 Jan; 163(1):61-6; discussion 66. PubMed ID: 15666642
[No Abstract] [Full Text] [Related]
16. Gene therapy for HIV infection: what does it need to make it work?
von Laer D; Hasselmann S; Hasselmann K
J Gene Med; 2006 Jun; 8(6):658-67. PubMed ID: 16598816
[TBL] [Abstract][Full Text] [Related]
17. Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials.
Clark JR; March JB
Trends Biotechnol; 2006 May; 24(5):212-8. PubMed ID: 16567009
[TBL] [Abstract][Full Text] [Related]
18. [Bacteriophage therapy revisited].
Kallings LO
Lakartidningen; 2009 Oct 14-20; 106(42):2708. PubMed ID: 19972672
[No Abstract] [Full Text] [Related]
19. Immunogenic effect of bacteriophage in patients subjected to phage therapy.
Kucharewicz-Krukowska A; Slopek S
Arch Immunol Ther Exp (Warsz); 1987; 35(5):553-61. PubMed ID: 3455646
[TBL] [Abstract][Full Text] [Related]
20. Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides.
Parisien A; Allain B; Zhang J; Mandeville R; Lan CQ
J Appl Microbiol; 2008 Jan; 104(1):1-13. PubMed ID: 18171378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
